Dov Elefant
CIK 1326487 · Chief Financial Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.5K
Companies
4
Total Filings
19
Lifetime Open-Market Net
$15.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FEMY | Chief Financial Officer | 2,922 | $2.92 | $8.5K | $0 | 9 | 2026-03-27 |
| CLRB | Chief Financial Officer | — | $2.50 | — | $0 | 1 | 2022-01-27 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Financial Officer | 11,755 | $0.12 | $1.4K | $15.0K | 6 | 2021-03-05 |
| AKTX | Chief Financial Officer | — | $8.43 | — | $0 | 1 | 2015-09-22 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-05 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Buy (P) | +7,407 | $10.0K | EDGAR |
| 2020-06-08 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Buy (P) | +4,348 | $5.0K | EDGAR |
| 2020-03-05 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | +10,000 | $27.1K | EDGAR |
| 2019-09-11 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-22 | AKTX | Grant (A) | — | $0 | EDGAR |
| 2008-10-21 | — | Disp (D) | — | $0 | |
| 2007-03-20 | — | Grant (A) | — | $0 |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.